Quick Answer
Korro Bio, Inc. reported Stockholders Equity of $51.44 million for fiscal year 2025.
Korro Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $51.44M | -67.9% |
| 2024 | $160.41M | -5.6% |
| 2023 | $169.91M | +271.6% |
| 2022 | -$99.03M | -134.6% |
| 2021 | -$42.21M | -121.9% |
| 2020 | $192.49M | +15.0% |
| 2019 | $167.36M | +446.6% |
| 2018 | -$48.28M | -62.9% |
| 2017 | -$29.64M | -206.8% |
| 2016 | -$9.66M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $99.03M | -44.9% | -14.0% |
| June 30, 2025 | $115.10M | -41.9% | -17.2% |
| March 31, 2025 | $138.96M | -8.2% | -13.4% |
| December 31, 2024 | $160.41M | -5.6% | -10.7% |
| September 30, 2024 | $179.63M | +217.2% | -9.3% |
| June 30, 2024 | $198.08M | +246.3% | +30.9% |
| March 31, 2024 | $151.36M | +228.0% | -10.9% |
| December 31, 2023 | $169.91M | +271.6% | +210.9% |
- Korro Bio, Inc. showed a decrease of -67.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Korro Bio, Inc.’s stockholders equity has grown by 632.3% (from -$9.66 million to $51.44 million).
- The most recent figure is from Korro Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: